InspireMD Inc
NASDAQ:NSPR

Watchlist Manager
InspireMD Inc Logo
InspireMD Inc
NASDAQ:NSPR
Watchlist
Price: 2.26 USD 1.8% Market Closed
Market Cap: 69.2m USD

Wall Street
Price Targets

NSPR Price Targets Summary
InspireMD Inc

Wall Street analysts forecast NSPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NSPR is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

Lowest
Price Target
4.04 USD
79% Upside
Average
Price Target
4.59 USD
103% Upside
Highest
Price Target
5.25 USD
132% Upside
InspireMD Inc Competitors:
Price Targets
HARTA
Hartalega Holdings Bhd
64% Upside
300888
Winner Medical Co Ltd
51% Upside
301101
Mingyue Optical Lens Co Ltd
8% Upside
KOSSAN
Kossan Rubber Industries Bhd
46% Upside
300595
Autek China Inc
23% Upside
9997
Kangji Medical Holdings Ltd
10% Upside
ALGN
Align Technology Inc
18% Upside
CERS
Cerus Corp
226% Upside

Revenue
Forecast

Revenue Estimate
InspireMD Inc

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 80%.

3%
Past Growth
80%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InspireMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
InspireMD Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NSPR's stock price target?
Price Target
4.59 USD

According to Wall Street analysts, the average 1-year price target for NSPR is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

What is InspireMD Inc's Revenue forecast?
Projected CAGR
80%

For the last 12 years the compound annual growth rate for InspireMD Inc's revenue is 3%. The projected CAGR for the next 3 years is 80%.

Back to Top